Capital Research Global Investors Added 9.9M Apple Shares While Cutting Meta in Q4 2025

Capital Research Global Investors, one of Capital Group's major equity divisions, did not need a dramatic portfolio overhaul to make a statement in Q4 2025. The filing still looks familiar at the top — Microsoft, NVIDIA, Broadcom, Eli Lilly, and Amazon remain the core. But the more revealing signal sits one layer lower: the firm added 9.9 million Apple shares in a single quarter, lifted Apple into the top seven, and cut Meta Platforms by roughly 5.9 million shares. For a $541.73B book, that is not noise. It suggests Capital Research Global Investors is still leaning into mega-cap growth, but with a more selective preference for platform durability, hardware exposure, and diversified AI infrastructure rather than simply owning every winner in the same proportions as the index.

TL;DR

• Scale stayed enormous: Capital Research Global Investors ended Q4 2025 with $541.73B in reported 13F assets across 434 holdings.
• The book barely widened: AUM rose from $532.97B in Q3 to $541.73B in Q4, while holdings count moved from 433 to 434.
• Apple was the clearest incremental bet: AAPL shares rose by 9.9M, a roughly 21.7% increase quarter over quarter.
• Meta was the clearest top-book trim: META fell by about 5.9M shares, even though it remained a top-10 position.
• Top-book concentration is real but not extreme: the top 10 positions account for roughly 38.95% of the filing.
• The read-through: this Capital Group division still wants big-tech and AI exposure, but it is expressing that view through a curated mix rather than a pure market-cap mirror.

Filing snapshot: large, steady, and still selective

This is the kind of filing that is easy to underestimate because nothing looks chaotic. But the stability is the point. Capital Group says it manages equity assets through three independent investment groups, and its research culture emphasizes first-hand global research plus analyst-run sleeves. That structure often produces portfolios that look diversified at a glance but still carry clear internal preferences. Here, the preference is for staying heavily exposed to the AI and quality-growth complex while reallocating within that cohort.

What did Capital Research Global Investors buy in Q4 2025?

The safest answer is: it bought more of what it already trusted. The firm kept Microsoft as its largest disclosed position, added more NVIDIA, added more Alphabet, and made a particularly visible push into Apple. It also added to Uber and kept meaningful exposure to RTX, which helps explain why the portfolio does not read like a simple Magnificent Seven clone.

There are also some telling secondary moves outside the very top. According to Holdings Channel's Q4 2025 summary, Capital Research Global Investors added heavily to Applied Materials, Oracle, Netflix, Philip Morris, and Halliburton. That matters because it broadens the story: this was not just an AI quarter. It was also a quarter for selective expansion into semicap, software, cash-flow defensives, and cyclicals.

Why the Apple build matters more than the Meta trim

Investors naturally notice the Meta reduction because it is large in share terms. But the more useful signal is the Apple increase. Meta had become a consensus winner across elite 13F filers by late 2025. Adding Apple instead says something subtler: Capital Research Global Investors seems willing to keep large exposure to digital platforms, but it may prefer a mix that leans a bit more toward installed-base durability, devices-plus-services cash generation, and ecosystem resilience. That interpretation fits with the firm's research-heavy process rather than a momentum chase.

The same pattern shows up elsewhere. NVIDIA rose, but Broadcom remained huge. Microsoft stayed number one. Amazon was trimmed, but not abandoned. In other words, the portfolio still wants the broad AI and cloud stack. It is just redistributing conviction across that stack.

AUM trend: bigger book, same basic philosophy

The multi-quarter trend also reinforces the idea that Capital Research Global Investors is scaling without becoming benchmark-shaped. Public 13F history from 13f.info shows disclosed AUM climbing from $441.98B in Q1 2024 to $541.73B in Q4 2025. Yet the holdings count remains in the low-400s. That is not hyper-concentrated, but it is disciplined for a manager of this size.

How this fits Capital Group's broader identity

Capital Group's own disclosures describe a firm built around independent investment groups, long-duration research, and portfolio sleeves run by both managers and analysts. That matters for readers trying to interpret this filing. A portfolio like this can hold Microsoft, NVIDIA, Eli Lilly, RTX, and Uber at meaningful scale without looking confused. It reflects multiple high-conviction views living inside one disciplined framework.

That also explains why the filing is more useful when read as a preference map than a list of isolated trades. The map says: keep the mega-cap platform core, add to selected AI winners, let healthcare remain large, keep industrial ballast, and trim some of the names that had become more consensus-heavy. For long-term readers, that is a more durable insight than simply noting which ticker moved up or down this quarter.

Sources and related reading

• SEC EDGAR filing history for CIK 0001422848
• 13f.info manager timeline and AUM history
• Holdings Channel top-holdings table
• Capital Group global disclosures
• Capital Group on first-hand global research
• Capital Group policies and disclosures
• Related: Capital World Investors Q4 2025
• Related: Capital International Investors Q4 2025

Conclusion

Capital Research Global Investors did not produce the flashiest Q4 2025 filing. It produced one of the clearer ones. The book got a bit bigger, stayed concentrated in high-quality franchises, and quietly shifted emphasis toward Apple, NVIDIA, and other selected growth names while reducing Meta and Amazon. For a Capital Group division built on deep research and independent sleeves, that looks less like short-term trading and more like a deliberate rebalancing inside a long-term compounder portfolio.